Lumibird has announced the selection of its subsidiary Quantel Medical's HoloDoppler project as part of the Health component of France 2030 financed by Bpifrance, with public funding of 2.8 million euros shared between Quantel Medical and its partners.

Working with leading ophthalmology research centers and hospitals, including the Quinze-Vingts, this project aims to create a new-generation medical device for quantitative, non-invasive angiography of the eye.

The market for retinal imaging devices is currently estimated at 800 million euros a year. HoloDoppler's goal is to reach the market within four years, with an eventual market share of around 5%.

Copyright (c) 2023 CercleFinance.com. All rights reserved.